PDB Short entry for 1QMN HEADER HYDROLASE INHIBITOR 04-OCT-99 1QMN TITLE ALPHA1-ANTICHYMOTRYPSIN SERPIN IN THE DELTA CONFORMATION (PARTIAL LOOP TITLE 2 INSERTION) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-1-ANTICHYMOTRYPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AACT, ACT, CELL GROWTH-INHIBITING GENE 24/25 PROTEIN, SERPIN COMPND 5 A3, ALPHA-1-ANTICHYMOTRYPSIN HIS-PRO-LESS; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD PLASMA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: N4830-1; SOURCE 9 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PZM-S; SOURCE 11 OTHER_DETAILS: THE MUTATION IS A NATURALLY OCCURRING VARIANT KEYWDS SERPIN, SERINE PROTEINASE INHIBITOR, HYDROLASE INHIBITOR LOOP-SHEET KEYWDS 2 POLYMERIZATION, EMPHYSEMA, DISEASE MUTATION, ACUTE PHASE PROTEIN, KEYWDS 3 CONFORMATIONAL DISEASE, HYDROLASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR B.GOOPTU,B.HAZES,D.A.LOMAS REVDAT 6 13-DEC-23 1QMN 1 REMARK REVDAT 5 08-MAY-19 1QMN 1 REMARK REVDAT 4 28-NOV-12 1QMN 1 HEADER COMPND KEYWDS REMARK REVDAT 4 2 1 VERSN SEQADV REVDAT 3 24-FEB-09 1QMN 1 VERSN REVDAT 2 30-APR-00 1QMN 1 DBREF REVDAT 1 17-JAN-00 1QMN 0 JRNL AUTH B.GOOPTU,B.HAZES,W.-S.W.CHANG,T.R.DAFFORN,R.W.CARRELL, JRNL AUTH 2 R.J.READ,D.A.LOMAS JRNL TITL INACTIVE CONFORMATION OF THE SERPIN ALPHA1-ANTICHYMOTRYPSIN JRNL TITL 2 INDICATES TWO-STAGE INSERTION OF THE REACTIVE LOOP: JRNL TITL 3 IMPLICATIONS FOR INHIBITORY FUNCTION AND CONFORMATIONAL JRNL TITL 4 DISEASE JRNL REF PROC.NATL.ACAD.SCI.USA V. 97 67 2000 JRNL REFN ISSN 0027-8424 JRNL PMID 10618372 JRNL DOI 10.1073/PNAS.97.1.67 REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.5 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MLF REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1393995.530 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 60.0 REMARK 3 NUMBER OF REFLECTIONS : 11373 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1036 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.27 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 72 REMARK 3 BIN R VALUE (WORKING SET) : 0.2973 REMARK 3 BIN FREE R VALUE : 0.3725 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 11 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2897 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.48700 REMARK 3 B22 (A**2) : 5.00500 REMARK 3 B33 (A**2) : 0.48200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -3.60600 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 500. REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.036 REMARK 3 BOND ANGLES (DEGREES) : 2.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.750 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.060 ; 0.015 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.550 ; 0.030 REMARK 3 SIDE-CHAIN BOND (A**2) : 7.570 ; 0.045 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 10.260; 0.090 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 49.66 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 86-89, 104-110, 122-125, AND REMARK 3 212-214 HAD VERY WEAK DENSITY. THEY HAVE BEEN LEFT IN THE REMARK 3 CONFORMATION OF THE MOLECULAR REPLACEMENT SEARCH MODEL (1AS4) REMARK 3 WHICH WAS DETERMINED AT HIGHER RESOLUTION. HOWEVER, REMARK 3 STEREOCHEMICAL PROBLEMS DO OCCUR IN THESE REGIONS. THE DENSITY REMARK 3 FOR THE SIDE CHAIN ATOMS OF RESIDUES: LYS 162, ILE 173, SER 348, REMARK 3 THR 351, LEU 358 AND SER 359 WAS ABSENT. THEREFORE NO ATOMS REMARK 3 BEYOND CB HAVE BEEN INCLUDED IN THE MODEL. ALA 398 WAS NOT REMARK 3 VISIBLE IN THE DENSITY REMARK 4 REMARK 4 1QMN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-OCT-99. REMARK 100 THE DEPOSITION ID IS D_1290004173. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-99 REMARK 200 TEMPERATURE (KELVIN) : 293.0 REMARK 200 PH : 4.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX7.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.448 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11373 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 41.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 62.1 REMARK 200 DATA REDUNDANCY : 1.700 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : 0.10100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 17.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.10 REMARK 200 R MERGE FOR SHELL (I) : 0.34300 REMARK 200 R SYM FOR SHELL (I) : 0.34300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1AS4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 MICROLITER OF 10MG/ML PROTEIN IN REMARK 280 50MM TRIS, 50MM KCL, PH 7.4 WAS MIXED WITH 2 MICROLITER OF REMARK 280 PRECIPITANT AND EQUILIBRATED AS A HANGING DROP OVER 1ML OF REMARK 280 PRECIPITANT (20% [W/V] PEG 4000, 0.2M AMMONIUM SULPHATE, 0.1M REMARK 280 NAOAC, PH 4.5), AT 18 DEGREES C, PH 4.50, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 61.04700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 RESIDUE 55 HAS BEEN MUTATED FROM LEU TO PRO. THIS MUTANT IS REMARK 400 A NATURALLY OCCURRING VARIANT WHICH HAS BEEN ASSOCIATED REMARK 400 WITH PLASMA DEFICIENCY AND CHRONIC OBSTRUCTIVE PULMONARY REMARK 400 DISEASE. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 SER A 2 REMARK 465 ASN A 3 REMARK 465 SER A 4 REMARK 465 PRO A 5 REMARK 465 LEU A 6 REMARK 465 ASP A 7 REMARK 465 GLU A 8 REMARK 465 GLU A 9 REMARK 465 ASN A 10 REMARK 465 LEU A 11 REMARK 465 THR A 12 REMARK 465 GLN A 13 REMARK 465 GLU A 14 REMARK 465 ASN A 15 REMARK 465 GLN A 16 REMARK 465 ASP A 17 REMARK 465 ARG A 18 REMARK 465 GLY A 19 REMARK 465 THR A 20 REMARK 465 HIS A 21 REMARK 465 VAL A 22 REMARK 465 ASP A 23 REMARK 465 LEU A 24 REMARK 465 GLY A 25 REMARK 465 LYS A 174 REMARK 465 ASP A 175 REMARK 465 LEU A 176 REMARK 465 ASP A 177 REMARK 465 VAL A 353 REMARK 465 LYS A 354 REMARK 465 ILE A 355 REMARK 465 THR A 356 REMARK 465 LEU A 357 REMARK 465 ALA A 398 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 162 CG CD CE NZ REMARK 470 ILE A 173 CG1 CG2 CD1 REMARK 470 SER A 348 OG REMARK 470 THR A 351 OG1 CG2 REMARK 470 LEU A 358 CG CD1 CD2 REMARK 470 SER A 359 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 70 -141.38 54.02 REMARK 500 ASN A 104 100.19 -49.84 REMARK 500 GLN A 105 73.32 -159.30 REMARK 500 SER A 107 -48.80 -166.78 REMARK 500 GLU A 109 -19.21 63.08 REMARK 500 GLN A 123 62.72 62.19 REMARK 500 ASP A 149 58.83 -110.50 REMARK 500 LEU A 172 140.21 -39.79 REMARK 500 GLN A 179 -93.92 -175.75 REMARK 500 THR A 180 108.61 165.37 REMARK 500 LYS A 213 2.71 -154.32 REMARK 500 HIS A 225 78.04 59.10 REMARK 500 THR A 351 120.94 176.92 REMARK 500 SER A 359 39.53 99.71 REMARK 500 THR A 364 -118.48 -151.94 REMARK 500 ARG A 365 -121.32 -32.38 REMARK 500 PRO A 373 127.98 -37.63 REMARK 500 ASP A 382 73.49 -105.20 REMARK 500 THR A 383 159.21 175.67 REMARK 500 GLN A 384 69.92 -112.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ACH RELATED DB: PDB REMARK 900 ALPHA1 ANTICHYMOTRYPSIN REMARK 900 RELATED ID: 3CAA RELATED DB: PDB REMARK 900 CLEAVED ANTICHYMOTRYPSIN A347R REMARK 900 RELATED ID: 4CAA RELATED DB: PDB REMARK 900 CLEAVED ANTICHYMOTRYPSIN T345R REMARK 900 RELATED ID: 1AS4 RELATED DB: PDB REMARK 900 CLEAVED ANTICHYMOTRYPSIN A349R REMARK 999 REMARK 999 SEQUENCE REMARK 999 MET 0, PART OF EXPRESSION VECTOR REMARK 999 ALA 1, PART OF EXPRESSION VECTOR REMARK 999 SER 2, PART OF EXPRESSION VECTOR REMARK 999 REMARK 999 RESIDUES THR 226A AND LEU 278A ARE NUMBERED WITH AN INSERT REMARK 999 CODE TO MATCH THE RESIDUE NUMBERING IN PDB ENTRY 1AS4 DBREF 1QMN A 3 398 UNP P01011 AACT_HUMAN 26 423 SEQADV 1QMN MET A 0 UNP P01011 EXPRESSION TAG SEQADV 1QMN ALA A 1 UNP P01011 EXPRESSION TAG SEQADV 1QMN SER A 2 UNP P01011 EXPRESSION TAG SEQADV 1QMN PRO A 55 UNP P01011 LEU 78 ENGINEERED MUTATION SEQRES 1 A 401 MET ALA SER ASN SER PRO LEU ASP GLU GLU ASN LEU THR SEQRES 2 A 401 GLN GLU ASN GLN ASP ARG GLY THR HIS VAL ASP LEU GLY SEQRES 3 A 401 LEU ALA SER ALA ASN VAL ASP PHE ALA PHE SER LEU TYR SEQRES 4 A 401 LYS GLN LEU VAL LEU LYS ALA PRO ASP LYS ASN VAL ILE SEQRES 5 A 401 PHE SER PRO PRO SER ILE SER THR ALA LEU ALA PHE LEU SEQRES 6 A 401 SER LEU GLY ALA HIS ASN THR THR LEU THR GLU ILE LEU SEQRES 7 A 401 LYS GLY LEU LYS PHE ASN LEU THR GLU THR SER GLU ALA SEQRES 8 A 401 GLU ILE HIS GLN SER PHE GLN HIS LEU LEU ARG THR LEU SEQRES 9 A 401 ASN GLN SER SER ASP GLU LEU GLN LEU SER MET GLY ASN SEQRES 10 A 401 ALA MET PHE VAL LYS GLU GLN LEU SER LEU LEU ASP ARG SEQRES 11 A 401 PHE THR GLU ASP ALA LYS ARG LEU TYR GLY SER GLU ALA SEQRES 12 A 401 PHE ALA THR ASP PHE GLN ASP SER ALA ALA ALA LYS LYS SEQRES 13 A 401 LEU ILE ASN ASP TYR VAL LYS ASN GLY THR ARG GLY LYS SEQRES 14 A 401 ILE THR ASP LEU ILE LYS ASP LEU ASP SER GLN THR MET SEQRES 15 A 401 MET VAL LEU VAL ASN TYR ILE PHE PHE LYS ALA LYS TRP SEQRES 16 A 401 GLU MET PRO PHE ASP PRO GLN ASP THR HIS GLN SER ARG SEQRES 17 A 401 PHE TYR LEU SER LYS LYS LYS TRP VAL MET VAL PRO MET SEQRES 18 A 401 MET SER LEU HIS HIS LEU THR ILE PRO TYR PHE ARG ASP SEQRES 19 A 401 GLU GLU LEU SER CYS THR VAL VAL GLU LEU LYS TYR THR SEQRES 20 A 401 GLY ASN ALA SER ALA LEU PHE ILE LEU PRO ASP GLN ASP SEQRES 21 A 401 LYS MET GLU GLU VAL GLU ALA MET LEU LEU PRO GLU THR SEQRES 22 A 401 LEU LYS ARG TRP ARG ASP SER LEU GLU PHE ARG GLU ILE SEQRES 23 A 401 GLY GLU LEU TYR LEU PRO LYS PHE SER ILE SER ARG ASP SEQRES 24 A 401 TYR ASN LEU ASN ASP ILE LEU LEU GLN LEU GLY ILE GLU SEQRES 25 A 401 GLU ALA PHE THR SER LYS ALA ASP LEU SER GLY ILE THR SEQRES 26 A 401 GLY ALA ARG ASN LEU ALA VAL SER GLN VAL VAL HIS LYS SEQRES 27 A 401 ALA VAL LEU ASP VAL PHE GLU GLU GLY THR GLU ALA SER SEQRES 28 A 401 ALA ALA THR ALA VAL LYS ILE THR LEU LEU SER ALA LEU SEQRES 29 A 401 VAL GLU THR ARG THR ILE VAL ARG PHE ASN ARG PRO PHE SEQRES 30 A 401 LEU MET ILE ILE VAL PRO THR ASP THR GLN ASN ILE PHE SEQRES 31 A 401 PHE MET SER LYS VAL THR ASN PRO LYS GLN ALA HELIX 1 1 LEU A 26 ALA A 45 1 20 HELIX 2 2 SER A 53 SER A 65 1 13 HELIX 3 3 LEU A 66 ALA A 68 5 3 HELIX 4 4 HIS A 69 LEU A 80 1 12 HELIX 5 5 SER A 88 ASN A 104 1 17 HELIX 6 6 LEU A 127 GLY A 139 1 13 HELIX 7 7 ASP A 146 GLN A 148 5 3 HELIX 8 8 ASP A 149 VAL A 161 1 13 HELIX 9 9 ASP A 199 THR A 203 5 5 HELIX 10 10 LYS A 259 ALA A 265 1 7 HELIX 11 11 LEU A 268 SER A 278 1 11 HELIX 12 12 LEU A 299 LEU A 306 1 8 HELIX 13 13 GLU A 309 THR A 313 5 5 SHEET 1 A 7 VAL A 50 PHE A 52 0 SHEET 2 A 7 ILE A 386 VAL A 392 -1 N LYS A 391 O VAL A 50 SHEET 3 A 7 PHE A 374 PRO A 380 -1 N ILE A 378 O PHE A 387 SHEET 4 A 7 ALA A 248 PRO A 255 -1 N ILE A 253 O LEU A 375 SHEET 5 A 7 CYS A 237 LYS A 243 -1 N LEU A 242 O ALA A 250 SHEET 6 A 7 LEU A 226 ASP A 232 -1 N ASP A 232 O CYS A 237 SHEET 7 A 7 GLU A 279 ILE A 283 -1 N ILE A 283 O LEU A 226 SHEET 1 B 6 GLU A 141 THR A 145 0 SHEET 2 B 6 GLN A 111 LYS A 121 1 N MET A 118 O GLU A 141 SHEET 3 B 6 MET A 182 LYS A 191 -1 N LYS A 191 O GLN A 111 SHEET 4 B 6 GLY A 164 ASP A 171 -1 N ILE A 169 O MET A 182 SHEET 5 B 6 LEU A 327 VAL A 340 -1 N LYS A 335 O GLY A 164 SHEET 6 B 6 PHE A 291 ASN A 298 -1 N TYR A 297 O HIS A 334 SHEET 1 C 2 LYS A 191 LYS A 193 0 SHEET 2 C 2 GLY A 344 GLU A 346 -1 N THR A 345 O ALA A 192 SHEET 1 D 4 HIS A 204 TYR A 209 0 SHEET 2 D 4 TRP A 215 HIS A 224 -1 N MET A 220 O HIS A 204 SHEET 3 D 4 GLU A 285 PRO A 289 -1 N LEU A 288 O MET A 221 SHEET 4 D 4 ILE A 367 ARG A 369 1 N VAL A 368 O GLU A 285 CRYST1 41.723 122.094 41.724 90.00 101.03 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023967 0.000000 0.004672 0.00000 SCALE2 0.000000 0.008190 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024418 0.00000